From Policy to Practice: A Qualitative Exploration of Stakeholders’ Awareness and Experiences with the Implementation of the Zero-Tariff Executive Order on Critical Pharmaceutical Inputs

Introduction: To catalyse local manufacturing and reduce costs, Nigeria’s Zero-Tariff Executive Order for critical pharmaceutical inputs was promulgated as a strategic instrument to advance national medicines’ security. Whilst the policy is strategically positioned to deliver transformative benefits, empirical evidence on its early implementation and stakeholder experiences remains scarce. This study provides context specific insights into stakeholder awareness, experiences, and systemic constraints, offering evidence-based recommendations to ensure the policy delivers its intended national impact.
Methods: A qualitative design was employed to elicit in-depth insights from selected stakeholders within pharma companies identified to benefit from the initiative. Semi-structured interviews explored critical thematic areas. The study cohort comprised industry representatives and other relevant experts in the manufacturing industry. Data were transcribed verbatim and analysed thematically to yield overarching themes and sub-themes, with trustworthiness ensured through triangulation and CASP checklist application.
Results: The analysis revealed widespread awareness of the Order but highlighted the need for robust communication for experts who are unaware. Participants also indicated access to modest cost relief where exemptions were processed efficiently, whilst many eligible actors did not operationalise benefits. With regard to barriers, three key themes emerged from this study. These comprised regulatory and customs barriers, financial and economic pressures, and policy timeline and scope limitations. Stakeholders also put forward actionable recommendations, including extending the Order’s duration, periodically reviewing the exempted product list, harmonising HS codes, reforming customs and regulatory processes with transparent protocols, and establishing a multi-agency taskforce, among others.
Conclusion: In conclusion, urgent operational reforms and supportive policy measures are required to convert policy intent into measurable gains for local manufacturing, affordability and access.

Executive order, Tariff Exemption; Pharmaceutical inputs; Local Manufacturing; Policy implementation

1. Adigwe, O. P., Aboh, M. I., Bolaji, O. Q., Oparaugo, I. P., Adikwu, V., & Balogun, C. (2025). Implementation and Impact of the Presidential order on Exemption of Payment of Import Duty and VAT for Critical Pharmaceutical Inputs. International Journal of research and Innovation in Applied Science, 10(8): 1-12. https://doi.org/10.51584/IJRIAS.2025.100800001 [Google Scholar] [Crossref]

2. Akande-Sholabi, W., & Adebisi, Y. A. (2020). The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan African Medical Journal, 35(Supp 2). https://doi.org/10.11604/pamj.supp.2020.35.2.23671 [Google Scholar] [Crossref]

3. Campos, P. A., & Reich, M. R. (2019). Political analysis for health policy implementation. Health Systems & Reform, 5(3), 224–235. https://doi.org/10.1080/23288604.2019.1625251 [Google Scholar] [Crossref]

4. Castleberry, A., & Nolen, A. (2018). Thematic analysis of qualitative research data: Is it as easy as it sounds? Currents in Pharmacy Teaching and Learning. 10(6), 807-815. https://doi.org/10.1016/j.cptl.2018.03.019 [Google Scholar] [Crossref]

5. Creswell, J.W., & Poth, C.N. (2018) Qualitative Inquiry and Research Design Choosing among Five Approaches. 4th Edition, SAGE Publications, Inc., Thousand Oaks. [Google Scholar] [Crossref]

6. Dantata, B. S., & Ahmed, L. K. (2016). Problems and challenges of policy implementation for national development. Research on Humanities and Social Sciences, 6, 15. https://www.academia.edu/download/121676526/234675272.pdf [Google Scholar] [Crossref]

7. Fowler, L. (2021). How to implement policy: Coping with ambiguity and uncertainty. Public Administration, 99(3), 581–597. https://doi.org/10.1111/padm.12702 [Google Scholar] [Crossref]

8. Guerin, P. J., Singh-Phulgenda, S., & Strub-Wourgaft, N. (2020). The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? F1000Research, 9, 225. https://doi.org/10.12688/f1000research.23057.1 [Google Scholar] [Crossref]

9. Jaiyeola, T. (2024, January 24). Naira depreciation pushes drug imports to N900bn. Retrieved from https://punchng.com/naira-depreciation-pushes-drug-imports-to-n900bn/ [Google Scholar] [Crossref]

10. Jiang, Z. (2017). Trade Facilitation and Customs Compliance for Cost-Saving and Efficiency: Policies, Practices and Proposals: A China Case Study. Global Trade and Customs Journal, 12(11/12). [Google Scholar] [Crossref]

11. Khan, M. A., & Rauf, A. (2024). Promoting local production and active pharmaceutical ingredient (API) industry in low- and middle-income countries (LMICs): impact on medicines access and policy. (1). https://doi.org/10.1080/20523211.2024.2323683 [Google Scholar] [Crossref]

12. Kinda, M. T., & Barry, H. (2021). Exchange rate pass‐through to import prices: Evidence from a heterogeneous panel of West African countries. Review of Development Economics, 25(4), 2454–2472. https://doi.org/10.1111/rode.12803 [Google Scholar] [Crossref]

13. Mason, M. (2010). Sample size and saturation in PhD studies using qualitative interviews. Forum Qualitative Sozialforschung, 11(3), 19. https://doi.org/10.17169/fqs-11.3.1428 [Google Scholar] [Crossref]

14. National Agency for Food and Drug Administration and Control. (2024, June 29). NAFDAC jubilates and salutes Mr. President for the bold move to ensure drug and health security through the Executive Order (EO) [Press release]. Retrieved from https://nafdac.gov.ng/nafdac-jubilates-and-salutes-mrpresident-for-the-bold-move-to-ensure-drug-and-health-security-through-the-executive-order-eo/ [Google Scholar] [Crossref]

15. Obembe, T. A., Adenipekun, A. B., Morakinyo, O. M., & Odebunmi, K. O. (2022). Implications of national tax policy on local pharmaceutical production in a southwestern state Nigeria – qualitative research for the intersection of national pharmaceutical policy on health systems development. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07579-1 [Google Scholar] [Crossref]

16. Ojuroungbe, S. (2024, December 29). Non-implementation of executive order frustrating drug price reduction – Stakeholders. Punch. Retrieved from https://punchng.com/non-implementation-ofexecutive-order-frustrating-drug-price-reduction-stakeholders/ [Google Scholar] [Crossref]

17. Perehudoff, K. (2020). Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators. Global Health Action, 13(1). https://doi.org/10.1080/16549716.2019.1699342 [Google Scholar] [Crossref]

18. Vu, H. T. (2016). Assessing potential impacts of the EVFTA on Vietnam’s pharmaceutical imports from the EU: an application of SMART analysis. Springer Plus, 5(1). https://doi.org/10.1186/s40064016-3200-7 [Google Scholar] [Crossref]

19. Wagner, O. (2023). The connection formula in classifying goods under the Harmonized System (HS) Convention. World Customs Journal, 17(2), 59–78. https://doi.org/10.55596/001c.88843 [Google Scholar] [Crossref]

20. Yusuf, A. (2024, July 4). Tax exemptions to propel local production of medicines. Retrieved from https://thenationonlineng.net/tax-exemptions-to-propel-local-production-of-medicines/ [Google Scholar] [Crossref]